Sign up to save your podcasts
Or
Share Safety Measures for Blood Products for SARS-CoV-2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Safety Measures for Blood Products for SARS-CoV-2
Description:
There are several measures to ensure safety in blood products, and one of them is Pathogen Reduction Technology (PRT) which is used in some instances by blood banks to help make blood transfusions safer for patients by reducing the pathogen load of a broad range of disease-causing viruses, bacteria, and parasites and help reduce transfusion reactions in patients. With COVID-19 rapidly spreading across the globe, blood banks may consider pathogen reduction technology as an added processing step to help ensure an adequate and safe supply of blood for patients.
This Podcast will provide background on the virology of SARS-CoV-2 and PRT, as well as reviewing the scientific evidence supporting the usefulness of safety measures in protecting transfusion patients from this new virus.
About our Speaker:
Dr. Raymond P. Goodrich is the Executive Director of the Infectious Disease Research Center and a professor of Immunology and Pathology in the Department of Microbiology at Colorado State University. His research group is currently focused on methods to safeguard blood transfusion products and to create and rapidly produce novel vaccine formulations that can be used to address infectious diseases.
View all episodes
By QuidelOrtho
4.9
1515 ratings
Description:
There are several measures to ensure safety in blood products, and one of them is Pathogen Reduction Technology (PRT) which is used in some instances by blood banks to help make blood transfusions safer for patients by reducing the pathogen load of a broad range of disease-causing viruses, bacteria, and parasites and help reduce transfusion reactions in patients. With COVID-19 rapidly spreading across the globe, blood banks may consider pathogen reduction technology as an added processing step to help ensure an adequate and safe supply of blood for patients.
This Podcast will provide background on the virology of SARS-CoV-2 and PRT, as well as reviewing the scientific evidence supporting the usefulness of safety measures in protecting transfusion patients from this new virus.
About our Speaker:
Dr. Raymond P. Goodrich is the Executive Director of the Infectious Disease Research Center and a professor of Immunology and Pathology in the Department of Microbiology at Colorado State University. His research group is currently focused on methods to safeguard blood transfusion products and to create and rapidly produce novel vaccine formulations that can be used to address infectious diseases.